Clinical Trial Update: The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of CKD-501 added to D150 Plus D759 therapy in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CKD-501
• D150
• D759 (D759)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type2 Diabetes | Phase 3 | Status: UNKNOWN